PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol
Food supplement declared in France, declaration No 2020-10-917, decision dated 21 October 2020
PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol (HERBIER DU VELAY) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chrysanthellum americanum 375 mg per day, Juglans regia 375 mg per day, Vaccinium myrtillus 375 mg per day, Olea europaea 375 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- HERBIER DU VELAY
- Food business operator placing the product on the market
- SAS VECTEUR ENERGY
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 10
- Directions for use
- Prendre 5ml (1cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant utili
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant
Declaration 209202, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Chrysanthellum americanum (L.) Vatke | Sommités fleuries | Macérât hydroglycériné | 375 mg |
| Juglans regia L. | Parties aériennes | Macérât hydroglycériné | 375 mg |
| Vaccinium myrtillus L. | Feuille | Macérât hydroglycériné | 375 mg |
| Olea europaea L. | Feuille | Macérât hydroglycériné | 375 mg |
Additives
E422
Other ingredients
Vin rouge
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Olea europaea L.
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HERBIER DU VELAY
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/209202-phytospagyrie-n-4-metabolisme-glucides-lipides-cholesterol, updated 15 November 2026.